| Ytd | -36.00% | |
| 1y | -78.01% |
| Open | 0.72 | Prev Close | 0.69 | Low | 0.70 | High | 0.72 | Mkt Cap | 20.56M |
| Vol | 25.20K | Avg Vol | 120.79K | EPS | -3.60 | P/E | -0.20 | Forward P/E | -4.00 |
| Beta | 0.54 | Short Ratio | 0.36 | Inst. Own | 14.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.76 | 200-d Avg | 1.20 | 1yr Est | 2.50 |
CELU News
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m
Gainers Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's
On June 29, 2026, Celularity Inc. (the "Company") entered into a Loan Agreement (the "L
FLORHAM PARK, N.J. and ORLANDO, Fla.
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" o
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” o
- Celularity Inc. (NASDAQ:CELU) (the "Company"), a longevity-focused regenerative and cellul
FLORHAM PARK, N.J., May 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”),
Entry into a Material Definitive Agreement. As previously disclosed by Celularity Inc. (the "Com
Company advances focused strategy, strengthens balance sheet and positions business for long-term gr
Veteran Financial and M&A Leader Appointed to Integrate Acquisition of Celularity, Scale the Busines
Transaction expected to approximately triple NEXGEL's annual revenue to approximately $35 million an
FLORHAM PARK, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”)
FLORHAM PARK, N.J., April 17, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”
Celularity (NASDAQ: CELU - Get Free Report) and KALA BIO (NASDAQ: KALA - Get Free Report) are both s
FLORHAM PARK, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”
The transaction represents the most significant milestone in the company's history.
FLORHAM PARK, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”
FLORHAM PARK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
While Celularity's Biovance® and Biovance 3L products remained eligible for Medicare coverage under
FLORHAM PARK, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
FLORHAM PARK, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
FLORHAM PARK, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday'
Company on Friday, August 29, 2025, filed quarterly reports on Form 10-Q for the periods ended March
Tuesday saw 132 companies set new 52-week lows.
During Wednesday's session, 117 stocks hit new 52-week lows.
On Tuesday, 164 companies hit new 52-week lows.
Friday's session saw 100 companies set new 52-week lows.
On Monday, 89 stocks made new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
During Friday's session, 574 stocks hit new 52-week lows.
On Friday, 72 companies set new 52-week lows.
During Wednesday's session, 340 companies made new 52-week lows.
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck a
On Wednesday, 329 companies hit new 52-week lows.
Upgrades
Tuesday morning saw 454 companies set new 52-week lows.
During Friday's session, 445 companies made new 52-week lows.
Upgrades